The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Khem Sum Apparels Overseas Ltd
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 3.6 pts more than Nifty Microcap 250 and 4.2 pts more than its Pharmaceuticals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
Khem Sum Apparels Overseas Ltd, part of the promoter group of Bacil Pharma Ltd, has sold its entire remaining holding of 200 equity shares (0.001% of total share capital) via an off-market transaction on 29 December 2025. Before the sale, the entity held 200 shares (0.001%); after the sale, its holding is nil. Total equity share capital of Bacil Pharma remains unchanged at 14,353,000 shares of Rs. 10 each. The disclosure was filed under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011.
This is a negligible transaction — just 200 shares representing 0.001% of the company — so it has no material impact on shareholding structure, liquidity, or stock price. Retail investors should not read this as any meaningful promoter exit signal.